China Nepstar Chain Drugstore Company Profile (NYSE:NPD)

Consensus Ratings for China Nepstar Chain Drugstore (NYSE:NPD)(?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.

Insider Trading History for China Nepstar Chain Drugstore (NYSE:NPD)No insider trades for this company have been tracked by Analyst Ratings Network

About China Nepstar Chain Drugstore

China Nepstar Chain Drugstore Ltd. (China Nepstar) is a retail drugstore chain in China. As of December 31, 2012, its store network was comprised of 2,132 directly operated drugstores. The Company provides its customers with professional and convenient pharmacy services and a variety of other merchandise, including over-the-counter (OTC) drugs, nutritional supplements, herbal products, personal care products, family care products, as well as convenience products including consumable, seasonal and promotional items. As of December 31, 2012, the Company had developed 2,019 private label products. In 2012, the Company's disposed the eight stores it acquired from Wenzhou Ren Ren Hao Chain Drugstore Co., Ltd. During December 31, 2012, the Company closed 319 stores and opened 56 new stores.

Subscribe

Subscribe to ARN Daily and get analysts' upgrades, downgrades and new coverage delivered directly to your email inbox daily using the form below:

Recent Ratings

Alacer Gold Corp (ASR) had its price target raised by analysts at Scotiabank from C$2.75 to C$3.25. They now have a "sector perform" rating on the stock. (3/31/2015)

Belo Sun Mining Corp (BSX) had its price target lowered by analysts at Scotiabank from C$0.70 to C$0.60. They now have a "sector perform" rating on the stock. (3/31/2015)

Gildan Activewear Inc (GIL) had its price target lowered by analysts at Scotiabank from C$82.00 to C$42.00. They now have an "outperform" rating on the stock. (3/31/2015)

WSP Global Inc (WSP) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a C$48.00 price target on the stock, up previously from C$46.00. (3/31/2015)